Freeline Therapeutics Holdings plc
NASDAQ:FRLN
6.49 (USD) • At close February 16, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q2 | 2019 Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||||
| Current Assets: | ||||||||||||||
| Cash & Cash Equivalents
| 29.452 | 38.797 | 55.415 | 47.279 | 65.848 | 89.998 | 113.098 | 117.662 | 136.377 | 164.682 | 195.765 | 229.974 | 106.61 | 73.702 |
| Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 29.452 | 38.797 | 55.415 | 47.279 | 65.848 | 89.998 | 113.098 | 117.662 | 136.377 | 164.682 | 195.765 | 229.974 | 106.61 | 73.702 |
| Net Receivables
| 2.823 | 3.119 | 1.527 | 1.23 | 2.964 | 2.66 | 2.526 | 2.211 | 17.322 | 17.333 | 16.736 | 16.114 | 17.032 | 11.503 |
| Inventory
| 0.768 | 1.061 | 3.772 | 17.644 | 4.044 | 2.142 | 3.997 | 6.418 | 1.786 | 1.561 | 1.605 | 3.08 | 1.927 | 0.842 |
| Other Current Assets
| 0.953 | 2.836 | 3.155 | 1.474 | 1.248 | 1.313 | 2.728 | 2.001 | 3.053 | 4.728 | 9.377 | 9.008 | 4.312 | 2.999 |
| Total Current Assets
| 33.996 | 45.813 | 63.869 | 67.627 | 74.104 | 96.113 | 122.349 | 128.292 | 158.538 | 188.304 | 223.483 | 258.176 | 129.881 | 89.046 |
| Non-Current Assets: | ||||||||||||||
| Property, Plant & Equipment, Net
| 12.551 | 14.076 | 14.782 | 15.021 | 22.489 | 62.278 | 69.69 | 9.906 | 10.141 | 10.05 | 10.093 | 8.608 | 6.755 | 7.272 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0.006 | 0.008 | 0 | 0 | 0.016 | 0.023 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | -1.327 | 0.003 | 0.004 | 0.006 | 0.008 | 0.01 | 0.011 | 0.016 | 0.023 | 0.032 | 0.043 |
| Long Term Investments
| 0 | 0 | 0 | 1.327 | 1.211 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0.523 | 0.542 | 0.533 | 0.533 | 0.377 | 0.377 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 2.149 | 2.222 | 2.182 | 3.46 | 1.891 | 3.362 | 4.128 | 2.919 | 2.077 | 2.689 | 1.655 | 1.805 | 3.795 | 1.029 |
| Total Non-Current Assets
| 15.223 | 16.84 | 17.497 | 19.014 | 25.971 | 66.021 | 73.824 | 12.833 | 12.228 | 12.75 | 11.764 | 10.436 | 10.582 | 8.344 |
| Total Assets
| 49.219 | 62.653 | 81.366 | 86.641 | 100.075 | 162.134 | 196.173 | 141.125 | 170.766 | 201.054 | 235.247 | 268.612 | 140.463 | 97.39 |
| Liabilities & Equity: | ||||||||||||||
| Current Liabilities: | ||||||||||||||
| Account Payables
| 7.778 | 6.875 | 12.453 | 10.058 | 9.956 | 7.881 | 9.141 | 5.187 | 5.665 | 4.55 | 5.528 | 8.093 | 12.862 | 5.817 |
| Short Term Debt
| 2.286 | 2.842 | 2.75 | 2.663 | 2.882 | 11 | 7.412 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 7.13 | 8.878 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities
| 0.283 | 0.085 | 7.538 | 18.245 | 9.578 | 7.217 | 8.841 | 15.497 | 12.303 | 10.873 | 10.292 | 10.719 | 8.621 | 6.617 |
| Total Current Liabilities
| 17.477 | 18.68 | 22.741 | 30.966 | 22.416 | 26.098 | 25.394 | 20.684 | 17.968 | 15.423 | 15.82 | 18.812 | 21.483 | 12.434 |
| Non-Current Liabilities: | ||||||||||||||
| Long Term Debt
| 1.702 | 1.957 | 2.639 | 3.261 | 9.077 | 46.407 | 52.217 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Liabilities
| 1.702 | 1.957 | 2.639 | 3.261 | 9.077 | 46.407 | 52.217 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities
| 19.179 | 20.637 | 25.38 | 34.227 | 31.493 | 72.505 | 77.611 | 20.684 | 17.968 | 15.423 | 15.82 | 18.812 | 21.483 | 12.434 |
| Equity: | ||||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0.137 | 0.137 | 0.137 | 0.137 | 0.137 | 0 | 0.001 | 0.001 |
| Common Stock
| 0.137 | 0.137 | 0.137 | 0.137 | 0.137 | 0 | 0 | -9.609 | 0 | 0 | 0 | 0 | 0.153 | 0 |
| Retained Earnings
| -472.286 | -460.198 | -444.187 | -445.353 | -422.354 | -407.461 | -383.114 | -356.381 | -321.681 | -290.805 | -250.935 | -215.99 | -152.932 | -119.668 |
| Accumulated Other Comprehensive Income/Loss
| -1.567 | -0.784 | -1.718 | -3.151 | -8.852 | -1.496 | 6.742 | 9.472 | 9.057 | 14.195 | 11.368 | 9.342 | -7.165 | -2.999 |
| Other Total Stockholders Equity
| 503.756 | 502.861 | 501.754 | 500.781 | 499.651 | 498.586 | 494.797 | 476.822 | 465.285 | 462.104 | 458.857 | 456.448 | 278.923 | 207.622 |
| Total Shareholders Equity
| 30.04 | 42.016 | 55.986 | 52.414 | 68.582 | 89.629 | 118.562 | 120.441 | 152.798 | 185.631 | 219.427 | 249.8 | 118.98 | 84.956 |
| Total Equity
| 30.04 | 42.016 | 55.986 | 52.414 | 68.582 | 89.629 | 118.562 | 120.441 | 152.798 | 185.631 | 219.427 | 249.8 | 118.98 | 84.956 |
| Total Liabilities & Shareholders Equity
| 49.219 | 62.653 | 81.366 | 86.641 | 100.075 | 162.134 | 196.173 | 141.125 | 170.766 | 201.054 | 235.247 | 268.612 | 140.463 | 97.39 |